Agneta Norén
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Oncology 9
- Drug Transport and Resistance Mechanisms 6
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Per Artursson (8 shared papers)Jacek R. Wiśniewski (6 shared papers)Anna Vildhede (5 shared papers)Maria Karlgren (3 shared papers)Louise Olsson (1 shared paper)Henrik Eriksson (1 shared paper)Frans Duraj (7 shared papers)Edward L. LeCluyse (1 shared paper)
- Journals
- HPB (4 papers)Molecular Pharmaceutics (2 papers)Drug Metabolism and Disposition (2 papers)Journal of Hepatology (1 paper)Journal of Proteomics (1 paper)
- Partner nations
- SwedenGermanyUnited States
In The Last Decade
Agneta Norén
19 papers receiving 834 citations
Peers
Comparison fields: 5 of 84
- Hepatology 195
- Pharmacology 220
- Oncology 352
- Pediatrics, Perinatology and Child Health 122
- Biotechnology 47
Countries citing papers authored by Agneta Norén
This map shows the geographic impact of Agneta Norén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta Norén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta Norén more than expected).
Fields of papers citing papers by Agneta Norén
This network shows the impact of papers produced by Agneta Norén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta Norén. The network helps show where Agneta Norén may publish in the future.
Co-authors
The 25 scholars most cited alongside Agneta Norén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 144 | |
| 2 | 2013 | 114 | |
| 3 | 2017 | 103 | |
| 4 | 2014 | 98 | |
| 5 | 2015 | 94 | |
| 6 | 2015 | 61 | |
| 7 | 2017 | 54 | |
| 8 | 2018 | 40 | |
| 9 | 2016 | 27 | |
| 10 | 2018 | 26 | |
| 11 | 2017 | 22 | |
| 12 | 2020 | 17 | |
| 13 | 2011 | 16 | |
| 14 | 2012 | 10 | |
| 15 | 2010 | 8 | |
| 16 | 2012 | 4 | |
| 17 | 2008 | 3 | |
| 18 | 2016 | 1 | |
| 19 | 2016 | 1 | |
| 20 | Comparative proteomics of human liver tissue and hepatocytes reveal systematic differences in proteins determining hepatic drug exposure | 2015 | 0 |
About Agneta Norén
Agneta Norén is a scholar working on Hepatology, Oncology, Pharmacology, Epidemiology and Spectroscopy, having authored 20 papers that have together received 843 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Drug Transport and Resistance Mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Pancreatic and Hepatic Oncology Research (2 papers), Mass Spectrometry Techniques and Applications (2 papers), Microbial Inactivation Methods (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Hepatology (195 citations), Pharmacology (220 citations), Oncology (352 citations), Pediatrics, Perinatology and Child Health (122 citations) and Biotechnology (47 citations). Agneta Norén has collaborated with scholars based in Sweden, Germany and United States. Frequent co-authors include Per Artursson, Jacek R. Wiśniewski, Anna Vildhede, Maria Karlgren, Louise Olsson, Henrik Eriksson, Frans Duraj, Edward L. LeCluyse, U Haglund and Jenny M. Pedersen. Their work appears in journals such as HPB, Molecular Pharmaceutics, Drug Metabolism and Disposition, Journal of Hepatology and Journal of Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.